Hong Kong Ordinances

HUMAN REPRODUCTIVE TECHNOLOGY ORDINANCE - SECT 16

Prohibition against commercial dealings in prescribed substance

(1) No person shall-

   (a)  whether in Hong Kong or elsewhere, make or receive any payment for the
        supply of, or for an offer to supply, a prescribed substance intended
        to be used for the purposes of any reproductive technology  procedure,
        embryo research or surrogacy arrangement;

   (b)  seek to find a person willing to supply for payment a
        prescribed substance referred to in paragraph (a);

   (c)  initiate or negotiate any arrangement involving the making of any
        payment for the supply of, or for an offer to supply, a prescribed 
        substance referred to in paragraph (a); or

   (d)  take part in the management or control of a body of persons corporate
        or unincorporate whose activities consist of or include the initiation
        or negotiation of any arrangement referred to in paragraph (c).

(2) Without prejudice to the generality of subsection (1)(b), no person shall
cause to be published or distributed, or knowingly publish or distribute, an
advertisement-

   (a)  inviting persons to supply for payment a prescribed substance referred
        to in subsection (1)(a) or offering to supply any such prescribed 
        substance for payment; or

   (b)  indicating that the advertiser is willing to initiate or negotiate any
        arrangement referred to in subsection (1)(c).

(3) In this section, "prescribed substance" (訂明物質) means-

   (a)  a gamete or embryo; or

   (b)  fetal ovarian, or fetal testicular, tissue.

"prescribed substance" (訂明物質)